Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 5

Serum prolidase level in patients with brucellosis and its possible relationship with pathogenesis of the disease: a prospective observational study

Pages
1479–1483
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The increase in serum prolidaselevels might be related to several factors such as tissue destruction, increased fibroblastic activity, and granuloma formation, all of whichare involved in the natural history of brucellosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Changes in collagen metabolism and fibroblastic activity may play a role in the pathogenesis of brucellosis.
📊
Key Findings & Data:We aimed to investigate the association of prolidase levels with brucellosis.Materials and methods: Serum prolidase levels in 20 patients newly diagnosed with brucellosis were compared with levels in 30 healthycontrol subjects.
💡
Conclusion & Impact:The increase in serum prolidaselevels might be related to several factors such as tissue destruction, increased fibroblastic activity, and granuloma formation, all of whichare involved in the natural history of brucellosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Changes in collagen metabolism and fibroblastic activity may play a role in the pathogenesis of brucellosis. Theprolidase enzyme plays an important role in collagen synthesis. We aimed to investigate the association of prolidase levels with brucellosis.Materials and methods: Serum prolidase levels in 20 patients newly diagnosed with brucellosis were compared with levels in 30 healthycontrol subjects. Patients with brucellosis were reassessed 3 months later for prolidase, other laboratory measurements, and responseto treatment.Results: The levels of serum prolidase were significantly higher in brucellosis patients compared with those of healthy controls. Prolidase,sedimentation, and C-reactive protein levels were significantly lower after antibrucellosis treatment than before treatment.Conclusion: The current study is the first to demonstrate significantly increased serum prolidase levels in patients with brucellosiscompared with healthy controls. Prolidase levels also significantly decreased with antibrucellosis treatment. This finding provides a newexperimental basis to understand the pathogenesis of brucellosis in relation to collagen metabolism. The increase in serum prolidaselevels might be related to several factors such as tissue destruction, increased fibroblastic activity, and granuloma formation, all of whichare involved in the natural history of brucellosis.

🔖

Cite This Article

ÖZDEMİR, A. T., KATIRCILAR, Y., DİZDAR, O. S., KOÇER, D., BAŞPINAR, O., ÇELİK, İ. (2022). Serum prolidase level in patients with brucellosis and its possible relationship with pathogenesis of the disease: a prospective observational study. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 5, 1479–1483. https://ajindex.com/articles/610036

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Sanaei Dashti A, Karimi A. Skeletal involvement of brucella melitensis in children: a systematic review. Iranian Journal of Medical Sciences 2013; 38(4): 286-292
  2. Horoz M, Aslan M, Bolukbas FF, Bolukbas C, Nazligul Y et al. Serum prolidase enzyme activity and its relation to histopathological findings in patients with nonalcoholic steatohepatitis. Journal of Clinical Laboratory Analysis 2010; 24(3): 207-211. doi: 10.1002/jcla.20334 3. Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: Biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 1994; 79(1): 13-18
  3. Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cellular Biochemistry 1997; 67(2): 166-175
  4. Surazynski A, Miltyk W, Palka J, Phang JM. Prolidasedependent regulation of collagen biosynthesis. Amino Acids 2008; 35(4): 731-738. doi: 10.1007/s00726-008-0051-8 6. Mert A, Ozaras R, Tabak F, Bilir M, Yilmaz M et al. The sensitivity and specificity of Brucella agglutination tests. Diagnostic Microbiology and Infectious Disease 2003; 46(4): 241-243
  5. Phang JM, Liu W, Zabirnyk O. Proline metabolism and microenvironmental stress. Annual Review of Nutrition 2010; 30: 441-463. doi: 10.1146/annurev.nutr.012809.104638 8. Kurien BT, Patel NC, Porter AC, D’Souza A, Miller D et al. Prolidase deficiency and the biochemical assays used in its diagnosis. Analytical Biochemistry 2005; 349(2): 165-175. doi: 10.1016/j.ab.2005.10.018
  6. Myara I, Marcon P, Lemonnier A, Chatelier B, Mangeot M. Determination of prolidase activity in plasma. Application to liver disease and its relation with prolidase activity. Clinical Biochemistry 1985; 18(4): 220-223
  7. Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clinical Chemistry 2002; 35(4): 263-268
  8. Bhatnager R, Nanda S, Dang AS. Plasma prolidase levels as a biomarker for polycystic ovary syndrome. Biomarkers in Medicine 2018; 12: 597-606. doi: 10.2217/bmm-2017-0306 12. Celik A, Birer MN, Kilinc M. Serum prolidase activity in systemic sclerosis. Clinical Rheumatology 2017; 36: 1827-1832. doi: 10.1007/s10067-017-3677-7 13. Cakmak A, Zeyrek D, Atas A, Celik H, Aksoy N et al. Serum prolidase activity and oxidative status in patients with bronchial asthma. Journal of Clinical Laboratory Analysis 2009; 23 (2): 13